Browse Opportunities
Sign in
Your Workspace Save opportunities and track your application progress.
PostDoc Active English
Verified Official Source

Opportunity Details

Postdoc 'Targeted oligonucleotide delivery in inflammatory kidney diseases'

Salary
EUR 3,724 - 5,867 per month
Application Deadline
September 15, 2026
Contract Duration
18 months
Position Type
PostDoc
Date Posted
August 20, 2026
Research Field
Medicine
Department
Departement of Medical BioSciences
Source details may be limited

Some structured details on Opportunita may still be incomplete. Please read the official university page before applying.

Explicify summary

Offer Summary

Radboud University Medical Center in Nijmegen is recruiting a postdoctoral researcher for an 18‑month project on targeted oligonucleotide delivery in inflammatory kidney diseases, starting 1 October 2026 (later start possible). The role involves designing, executing and analysing experiments to optimise conjugation, targeting and toxicity of antisense, siRNA and mRNA formulations, in close collaboration with biotech partner Mercurna. Candidates should have experience in biomolecular conjugation, mass spectrometry, dynamic light scattering, and standard cell‑biological techniques; confocal microscopy is a plus. The position offers a salary of €3,724–€5,867 per month and requires a Certificate of Conduct (VOG).

Generated from stored offer content. Always confirm details in the official posting.

Project Description

Job description

Join our team as a postdoctoral researcher in an 18-month project, starting on 1 October 2026; a later start date can be accommodated.

Chronic inflammatory kidney diseases are a major health burden. Current treatment is symptomatic with significant systemic side effects. Oligonucleotides such as antisense oligonucleotides, siRNA and mRNA provide the possibility to specifically interfere with disease-causing processes, however, these molecules critically depend on effective targeting of the disease causing target cells.

In this application-oriented project, we will take strategies for cellular targeting and activity measurement of various types of oligonucleotides coupled to targeting ligands from an early to a late preclinical stage. For this purpose, coupling protocols and analytical protocols will be optimized and activity and toxicity studies for the various types of formulations performed.

You will independently design, perform and analyse experiments aimed at improving cellular targeting and advancing these formulations towards late-stage preclinical development.

The project is directed by and conducted in close collaboration with Mercurna, a biotech company developing targeted therapies for chronic inflammatory kidney disease. Mercurna is also located in Nijmegen, enabling a close coordination of activities.

Place of work

The work will take place at the Radboudumc in the group of Targeted Nanomedicines (Prof. Dr. Roland Brock) of the Departement of Medical BioSciences in close collaboration with Mercurna B.V.

Profile

You should have experience in biomolecular conjugation strategies and analytical techniques such as mass spectrometry and dynamic light scattering next to standard biochemical and cell biological techniques. Experience in confocal microscopy is desirable.

As this project will focus on process optimization and standardization, there should be a good understanding of the relevant degrees of freedom. You should be able to plan, execute and analyze experiments independently and carefully document protocols and results.

Good to know

  • This position requires a Certificate of Conduct (VOG).

We are recruiting for this position ourselves. Unsolicited marketing is not appreciated, but do feel free to share the vacancy in your network!


Academic Contact

Prof. Dr. Roland Brock Departement of Medical BioSciences
Last Update Radboud University Medical Center (Radboudumc) careersatradboudumc.com
Back to top
0%